EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis
Enhancer of zeste homolog 2 (EZH2) has been associated with poor prognosis in triple negative breast cancer (TNBC). Here, the authors suggest a potential role for trimethylation function of EZH2 in driving peritoneal metastasis in TNBC.
Main Authors: | Ayushi Verma, Akhilesh Singh, Manish Pratap Singh, Mushtaq Ahmad Nengroo, Krishan Kumar Saini, Saumya Ranjan Satrusal, Muqtada Ali Khan, Priyank Chaturvedi, Abhipsa Sinha, Sanjeev Meena, Anup Kumar Singh, Dipak Datta |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-35059-x |
Similar Items
-
Loss of PERK function promotes ferroptosis by downregulating SLC7A11 (System Xc⁻) in colorectal cancer
by: Krishan Kumar Saini, et al.
Published: (2023-09-01) -
Salinomycin inhibits epigenetic modulator EZH2 to enhance death receptors in colon cancer stem cells
by: Anup Kumar Singh, et al.
Published: (2021-02-01) -
Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
by: Aiswarya Chaudhuri, et al.
Published: (2023-05-01) -
Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
by: Desh Deepak Singh, et al.
Published: (2021-10-01) -
TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy
by: Desh Deepak Singh, et al.
Published: (2021-07-01)